Anouti, Ahmad
Al Hariri, Moustafa
VanWagner, Lisa B.
Lee, William M.
Mufti, Arjmand
Pedersen, Mark
Shah, Jigesh
Hanish, Steven
Vagefi, Parsia A.
Cotter, Thomas G.
Patel, Madhukar S. http://orcid.org/0000-0001-7508-899X
Article History
Received: 29 August 2023
Accepted: 4 January 2024
First Online: 21 February 2024
Declarations
:
: AA, MAH, and CH have no relevant disclosures. Dr. Patel is supported as the Dedman Scholar of Clinical Care at UT Southwestern Medical center. The funder had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation of the manuscript. Dr. Cotter is supported by the American Association for the Study of Liver Diseases (AASLD) Clinical, Translational and Outcomes Research Award (CTORA) and National Institute for Alcohol Abuse and Alcoholism (NIAAA) K23AA031310 grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Dr. Lee is supported by U01 DK58369 and by research support from Intercept, Aurora, Gilead, Novo Nordisk, Alexion, Eiger, Camurus and Lipocine and consults for Forma, SeaGen, GSK, Karuna, and Cortexyme. Dr. VanWagner is supported by NIH grant R56 HL155093 and by research support from W.L. Gore & Associates and the American Society for Transplantation, consults for Gerson Lehrman Group and Numares, and serves as an expert witness.